Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Ustekinumab is effective in biological refractory Crohn's disease patients-regardless of approval study selection criteria.

Saman S, Goetz M, Wendler J, Malek NP, Wehkamp J, Klag T.

Intest Res. 2019 May 31. doi: 10.5217/ir.2019.00012. [Epub ahead of print]

2.

Human Endogenous Retroviruses: Residues of Ancient Times Are Differentially Expressed in Crohn's Disease.

Klag T, Courth L, Ostaff MJ, Ott G, Stange EF, Malek NP, Seifarth W, Wehkamp J.

Inflamm Intest Dis. 2019 Feb;3(3):125-137. doi: 10.1159/000494026. Epub 2018 Nov 21.

3.

Tacrolimus Suppositories in Therapy-Resistant Ulcerative Proctitis.

Jaeger SU, Klag T, Hoeger K, Klumpp S, Escher M, Malek N, Stange E, Wehkamp J.

Inflamm Intest Dis. 2019 Feb;3(3):116-124. doi: 10.1159/000493979. Epub 2018 Nov 9.

4.

Paneth cell α-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments.

Ehmann D, Wendler J, Koeninger L, Larsen IS, Klag T, Berger J, Marette A, Schaller M, Stange EF, Malek NP, Jensen BAH, Wehkamp J.

Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3746-3751. doi: 10.1073/pnas.1817376116. Epub 2019 Feb 11.

5.

Quantification of Hemodynamic Changes in Chronic Liver Disease: Correlation of Perfusion-CT Data with Histopathologic Staging of Fibrosis.

Wm T, L S, C K, K E, T H, H B, T K, K N, M H, S K.

Acad Radiol. 2018 Dec 6. pii: S1076-6332(18)30524-5. doi: 10.1016/j.acra.2018.11.009. [Epub ahead of print]

PMID:
30528750
6.

Enterocutaneous fistula in severely active Crohn's disease: preoperative anti-TNF alpha treatment to limit bowel resection-report of a case.

Wilhelm P, Kirschniak A, Johannink J, Kaufmann S, Klag T, Wehkamp J, Falch C.

Int J Colorectal Dis. 2019 Feb;34(2):369-373. doi: 10.1007/s00384-018-3206-4. Epub 2018 Nov 29.

PMID:
30498853
7.

GLP-2 analog teduglutide significantly reduces need for parenteral nutrition and stool frequency in a real-life setting.

Schoeler M, Klag T, Wendler J, Bernhard S, Adolph M, Kirschniak A, Goetz M, Malek N, Wehkamp J.

Therap Adv Gastroenterol. 2018 Aug 30;11:1756284818793343. doi: 10.1177/1756284818793343. eCollection 2018.

8.

β-Defensin 1 Is Prominent in the Liver and Induced During Cholestasis by Bilirubin and Bile Acids via Farnesoid X Receptor and Constitutive Androstane Receptor.

Klag T, Thomas M, Ehmann D, Courth L, Mailänder-Sanchez D, Weiss TS, Dayoub R, Abshagen K, Vollmar B, Thasler WE, Stange EF, Berg CP, Malek NP, Zanger UM, Wehkamp J.

Front Immunol. 2018 Jul 27;9:1735. doi: 10.3389/fimmu.2018.01735. eCollection 2018.

9.

[Crohn's Disease - New Therapies].

Klag T, Wehkamp J.

Dtsch Med Wochenschr. 2018 Jul;113(13):953-959. doi: 10.1055/a-0538-3671. Epub 2018 Jul 4. Review. German.

PMID:
29972839
10.

Practical guidance for the management of iron deficiency in patients with inflammatory bowel disease.

Niepel D, Klag T, Malek NP, Wehkamp J.

Therap Adv Gastroenterol. 2018 Apr 26;11:1756284818769074. doi: 10.1177/1756284818769074. eCollection 2018. Review.

11.

Endoscopic Balloon Dilation for Crohn's Disease-Associated Strictures.

Klag T, Wehkamp J, Goetz M.

Clin Endosc. 2017 Sep;50(5):429-436. doi: 10.5946/ce.2017.147. Epub 2017 Sep 29. Review.

12.

High Demand for Psychotherapy in Patients with Inflammatory Bowel Disease.

Klag T, Mazurak N, Fantasia L, Schwille-Kiuntke J, Kirschniak A, Falch C, Goetz M, Malek NP, Enck P, Wehkamp J.

Inflamm Bowel Dis. 2017 Oct;23(10):1796-1802. doi: 10.1097/MIB.0000000000001216.

PMID:
28817460
13.

Low-grade appendiceal mucinous neoplasm (LAMN) - 3-year endoscopic follow-up underlines benign course of LAMN type 1.

Klag T, Wehkamp J, Bösmüller H, Falch C, Johannink J, Malek NP, Kirschniak A, Goetz M.

Z Gastroenterol. 2017 Feb;55(2):149-152. doi: 10.1055/s-0042-121495. Epub 2017 Feb 13.

PMID:
28192848
14.

Hepatitis C "true" late relapse beyond 48weeks of sustained virologic response after direct acting antiviral therapy.

Klag T, Dietz J, Werner CR, Schwarz JM, Lauer UM, Beck R, Malek NP, Sarrazin C, Berg CP.

J Hepatol. 2017 Apr;66(4):862-863. doi: 10.1016/j.jhep.2017.01.002. Epub 2017 Jan 9. No abstract available.

PMID:
28082147
15.

Interleukin-6 Kinetics can be Useful for Early Treatment Monitoring of Severe Bacterial Sepsis and Septic Shock.

Klag T, Cantara G, Sechtem U, Athanasiadis A.

Infect Dis Rep. 2016 Mar 21;8(1):6213. doi: 10.4081/idr.2016.6213. eCollection 2016 Mar 21.

16.

Medical Therapy of Perianal Crohn's Disease.

Klag T, Goetz M, Stange EF, Wehkamp J.

Viszeralmedizin. 2015 Aug;31(4):265-72. doi: 10.1159/000434664. Epub 2015 Jul 29. Review.

17.

Management of Crohn's disease - are guidelines transferred to clinical practice?

Klag T, Stange EF, Wehkamp J.

United European Gastroenterol J. 2015 Aug;3(4):371-80. doi: 10.1177/2050640615580228.

18.

Epicardial coronary artery spasm as cause of capecitabine-induced tako tsubo cardiomyopathy.

Klag T, Cantara G, Ong P, Kaufmann M, Sechtem U, Athanasiadis A.

Clin Res Cardiol. 2014 Mar;103(3):247-50. doi: 10.1007/s00392-013-0636-4. Epub 2013 Nov 26. No abstract available.

PMID:
24276117
19.

Defective antibacterial barrier in inflammatory bowel disease.

Klag T, Stange EF, Wehkamp J.

Dig Dis. 2013;31(3-4):310-6. doi: 10.1159/000354858. Epub 2013 Nov 14. Review.

PMID:
24246980
20.

Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib.

La Rosée P, Martiat P, Leitner A, Klag T, Müller MC, Erben P, Schenk T, Saussele S, Hochhaus A.

Ann Hematol. 2013 Oct;92(10):1345-50. doi: 10.1007/s00277-013-1769-2. Epub 2013 Apr 28.

PMID:
23625298
21.

Omacetaxine mepesuccinate prevents cytokine-dependent resistance to nilotinib in vitro: potential role of the common β-subunit c of cytokine receptors.

Klag T, Härtel N, Erben P, Schwaab J, Schnetzke U, Schenk T, Hochhaus A, La Rosée P.

Leukemia. 2012 Jun;26(6):1321-8. doi: 10.1038/leu.2011.380. Epub 2012 Jan 13.

PMID:
22289991
22.

Enhanced ABL-inhibitor-induced MAPK-activation in T315I-BCR-ABL-expressing cells: a potential mechanism of altered leukemogenicity.

Härtel N, Klag T, Hanfstein B, Mueller MC, Schenk T, Erben P, Hochhaus A, La Rosée P.

J Cancer Res Clin Oncol. 2012 Feb;138(2):203-12. doi: 10.1007/s00432-011-1086-x. Epub 2011 Nov 17.

PMID:
22089930
23.

Leriche's syndrome and Löffler endocarditis in a 30-year-old patient presenting with hypereosinophilic syndrome.

Klag T, Schnetzke U, Benz R, Zanow J, Glaser A, Pörner TC, Scholl S, Reiter A, Hochhaus A, La Rosée P.

Ann Hematol. 2012 Jan;91(1):139-41. doi: 10.1007/s00277-011-1232-1. Epub 2011 Apr 15. No abstract available.

PMID:
21494797

Supplemental Content

Loading ...
Support Center